Hyperion Therapeutics' IPO

Hyperion Therapeutics raised a round of funding on July 26, 2012. Investors include Public.

Hyperion Therapeutics is a privately held specialty therapeutics company focused on the development of therapies that address needs in the areas of gastroenterology and hepatology. In partnership with…

Articles about Hyperion Therapeutics' IPO: